Phythera Therapeutics Inc.

Phythera Therapeutics Inc. has raised $468 in total funding. The most recent round was Seed.

Phythera Therapeutics Inc. is headquartered in Irvine, CA.

Phythera Therapeutics, Inc. is a biotechnology company leveraging the power of natural compounds to modulate key biological pathways in cancer and tissue regeneration to improve human health.

Existing cancer treatments like radiation and chemotherapy cause significant harm to patients' health and quality of life, and developing safe multi-component drug cocktails is prohibitively expensive to test under traditional FDA rules.

Phythera converts nature-derived anti-cancer plant compounds into prescription oncology drugs by molecularly enhancing them, using tools like liposomal drug delivery and AI-driven small molecule design to improve their effectiveness.

The company leverages the FDA's 2016 Botanical Drug Development Guidance, which lets a botanical extract be treated as a single active ingredient and credits past human use, combined with its own method for further enhancing the extract's cancer-killing ability.